• Home
  • >
  • Aarti Pharmalabs Ltd Financials
https://storage.googleapis.com/assets.cdp.blinkx.in/BlinkxSearch/initials/a.svg Logo

Aarti Pharmalabs Ltd Financial Statement

Aarti Pharmalabs Ltd Income Statement
Quarterly
Annual

*All values are in Rs. Cr

(Rs. CR)Mar 2024Dec 2023Sep 2023
Revenue420.51373.49356.27
Operating Expense307.49284.76282.33
Net Profit63.0248.1941.81
Net Profit Margin14.9912.911.74
Earning Per Share6.955.324.61
EBIDTA96.4682.4972.44
Effective Tax Rate10.3514.6514.01

(Rs. Cr)

Revenue

Operating Expense

Net Profit

Net Profit Margin

Earning Per Share

EBIDTA

Effective Tax Rate

Aarti Pharmalabs Ltd Profit & Loss

*All values are in Rs. Cr

Consolidated
Standalone
ParticularsMar 2023Mar 2022Mar 2021
Total Revenue Annual1,945.231,199.94TBA
Operating Expenses Annual1,603.249930
Operating Profit Annual344.37209.46-0
Interest Annual21.0511.96TBA
Depreciation62.5442.12TBA
Net Profit Annual193.49122.25-0
Tax Annual67.2833.13TBA

Particulars

Total Revenue Annual

Operating Expenses Annual

Operating Profit Annual

Interest Annual

Depreciation

Net Profit Annual

Tax Annual

Aarti Pharmalabs Ltd Cash Flow

*All values are in Rs. Cr

Consolidated
Standalone
ParticularsMar 2023Mar 2022Mar 2021
Cash Flow at the Beginning83.275.330.25
Cash Flow from Operations263-43.7TBA
Cash Flow from Investing-157.8-138.74TBA
Cash Flow from Financing-163.47260.38TBA
Cash Flow at the End2583.270.25

Particulars

Cash Flow at the Beginning

Cash Flow from Operations

Cash Flow from Investing

Cash Flow from Financing

Cash Flow at the End

Aarti Pharmalabs Ltd Key Ratios

*All values are in Rs. Cr

Consolidated
Standalone
ParticularsMar 2023Mar 2022Mar 2021
PBDIT Margin (%)17.717.46TBA
PBIT Margin (%)14.4913.95TBA
PBT Margin (%)13.612.46TBA
Net PROFIT Margin (%)11.3611.34TBA
Return On Networth / Equity (%)13.1417.63TBA
Return On Networth /Employed(%)16.0919.37TBA
Return On Assets (%)12.6115.77TBA
Total Debt / Equity(X)0.20.250.01
Asset Turnover Ratio (%)1.111.39TBA

Particulars

PBDIT Margin (%)

PBIT Margin (%)

PBT Margin (%)

Net PROFIT Margin (%)

Return On Networth / Equity (%)

Return On Networth / Employed(%)

Return On Assets (%)

Total Debt / Equity(X)

Asset Turnover Ratio (%)

Aarti Pharmalabs Ltd Balance Sheet

*All values are in Rs. Cr

Consolidated
Standalone
ParticularsMar 2023Mar 2022Mar 2021
Fixed Assets Annual965.5804.23TBA
Total Current Assets Annual1,155.761,028.150.25
Non Current Assets Annual1,075.171,011.75TBA
Total Shareholders Funds Annual1,558.491,386.480.23
Total Assets Annual2,230.932,039.90.25

Particulars

Fixed Assets Annual

Total Current Assets Annual

Non Current Assets Annual

Total Shareholders Funds Annual

Total Assets Annual

Aarti Pharmalabs Ltd Earning Calls
Mar 2024
EPS beaten by 0.00 %

Open Demat Account

50years
*By signing up you agree to our terms & conditions
50 Years
of Trust & Legacy
₹0 AMC
for First Year
₹0 Brokerage
on Delivery, Intraday, Currency and NSE F&O

Dividend Pages

PE Ratio

Get Your FAQs Right

As of May 20, 2024, Aarti Pharmalabs Ltd has a market capitalization of 3,942.23 Cr. Value Research classifies it as a Mid-Cap company.

Yes, Aarti Pharmalabs Ltd is debt-free with a debt-to-equity ratio of 0.16.

In FY 2023, Aarti Pharmalabs Ltd recorded a total revenue of approximately 1,852.61 Cr marking a significant milestone in the company's financial performance.

Aarti Pharmalabs Ltd's Future outlook anticipates robust growth, with forecasted earnings and revenue rising approximately Infinity% and 0.2% annually, respectively..

Aarti Pharmalabs Ltd's current PE ratio is 18.18.

Aarti Pharmalabs Ltd's ROCE averaged 13.7% from the FY ending March 2022 to 2024, with a median of 15.6%. It peaked at 15.9% in March 2023, reflecting strong capital efficiency over the period..

Aarti Pharmalabs Ltd's latest EBIT is Rs. 317.7 Cr, surpassing the average EBIT of Rs. 255.62 Cr over the 5 years..